Scaling up circumcision programs in Southern Africa: The potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission

AIDS and Behavior

Volumn 15, Issue 5, 2011, Pages 938-948

  Andersson, Kyeen M ^a   Owens, Douglas K ^b,c   Paltiel, A David ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Africa; HIV prevention; Male circumcision; Mathematical models; Sexual behavior

Indexed keywords

ADULT; ARTICLE; CIRCUMCISION; CONDOM; DISEASE TRANSMISSION; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MATHEMATICS; PREVALENCE; RISK REDUCTION; SEX DIFFERENCE; SEXUALITY; SOUTH AFRICA; STATISTICS; THEORETICAL MODEL; UTILIZATION REVIEW;

ADULT; CIRCUMCISION, MALE; CONDOMS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; MALE; MATHEMATICS; MODELS, THEORETICAL; PREVALENCE; RISK REDUCTION BEHAVIOR; SEX FACTORS; SEXUAL PARTNERS; SOUTH AFRICA; YOUNG ADULT;

EID: 80052058454     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9784-y     Document Type: Article

References (74)

1. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657-66.
2. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643-56. (Pubitemid 46281312)
3. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):1112-22. (Pubitemid 41735779)
4. Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007;11(3):341-55. (Pubitemid 46570814)
5. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. 2006;332(7541):605-7. (Pubitemid 44365764)
6. Mattson CL, Campbell RT, Bailey RC, et al. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS ONE. 2008;3(6):e2443.
7. Wegbreit J, Bertozzi S, DeMaria LM, Padian NS. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS. 2006;20(9):1217-35. (Pubitemid 44030370)
8. Wawer MJ, Makumbi F, Kigozi G, et al. Circumcision in HIV infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009;374(9685):229-37.
9. Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, Weiss NS. Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr. 2007;44(1):66-70. (Pubitemid 46052222)
10. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008;22(5):567-74. (Pubitemid 351640589)
11. Eaton L, Kalichman SC. Behavioral aspects of male circumcision for the prevention of HIV infection. Curr HIV/AIDS Rep. 2009;6(4):187-93.
12. Berer M. Male circumcision for HIV prevention: what about protecting men's partners? Reprod Health Matters. 2008;16(32): 171-5.
13. Gruskin S. Male circumcision, in so many words. Reprod Health Matters. 2007;15(29):49-52.
14. Hankins C. Male circumcision: implications for women as sexual partners and parents. Reprod Health Matters. 2007;15(29):62-7. (Pubitemid 46734692)
15. Berer M. Male circumcision for HIV prevention: perspectives on gender and sexuality. Reprod Health Matters. 2007;15(29):45-8. (Pubitemid 46734687)
16. Gray RH, Li X, Kigozi G, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS. 2007;21(7): 845-50. (Pubitemid 46573156)
17. Williams BG, Lloyd-Smith JO, Gouws E, et al. The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med. 2006;3(7):1032-40. (Pubitemid 44125989)
18. Nagelkerke NJD, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007;7:16-30.
19. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006;3(12):2349-58. (Pubitemid 46026452)
20. Podder CN, Sharomi O, Gumel AB, Moses S. To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control. Bull Math Biol. 2007;69(8):2447-66. (Pubitemid 350029416)
21. Hallett TB, Singh K, Smith JA, et al. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS ONE. 2008;3(5):e2212.
22. White RG, Glynn JR, Orroth KK, et al. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS. 2008;22(14):1841-50.
23. Bollinger LA, Stover J, Musuka G, et al. The cost and impact of male circumcision on HIV/AIDS in Botswana. J Int AIDS Soc. 2009;12(1):7.
24. Londish GJ, Murray JM. Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epid. 2008;37(6):1246-53.
25. UNAIDS/WHO/SACEMA expert group on modelling the impact and cost of male circumcision for HIV prevention. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009;6(9):e1000109.
26. Andersson KM, Owens DK, Vardas E, Gray GE, McIntyre JA, Paltiel AD. Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: a South African example. J Acquir Immune Defic Syndr. 2007;46(1): 78-90. (Pubitemid 47507437)
27. Shisana O, Simbayi L. Nelson Mandela/HSRC study of HIV/AIDS: South African National HIV prevalence, behavioural risks and mass media: household survey 2002. Cape Town: Human Sciences Research Council Press; 2002.
28. Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS. 2005;19(14):1525-34. (Pubitemid 41400699)
29. Lagarde E, Dirk T, Puren A, Reathe R-T, Auvert B. Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa. AIDS. 2003;17(1): 89-95. (Pubitemid 36106302)
30. Wise J. Demand for male circumcision rises in a bid to prevent HIV. Bull World Health Organ. 2006;84(7):509-11.
31. Simbayi L, Strebel A, Wilson T et al. (1999) Sexually transmitted diseases in the south african public sector. Cape Town: National department of health's directorate of health systems research and epidemiology in conjunction with the directorate of HIV/AIDS and STDs; August.
32. Pettifor AE, Measham DM, Rees HV, Padian NS. Sexual power and HIV risk, South Africa. Emerg Infect Dis. 2004;10(11): 1996-2004. (Pubitemid 39458571)
33. Ackermann L, de Klerk GW. Social factors that make South African women vulnerable to HIV infection. Health Care Women Int. 2002;23(2):163-72.
34. Dunkle KL, Jewkes RK, Brown HC, et al. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet. 2004;363(9419): 1415-21. (Pubitemid 38586715)
35. The World Health Organization (WHO), the joint United nations programme on HIV/AIDS (UNAIDS), and the United nations children's fund (UNICEF). Toward universal access: scaling up priority HIV/AIDS interventions in the health sector: Progress Report 2008. Geneva: WHO. 2008.
36. Andersson KM, Van Niekerk RM, Niccolai LM, et al. Sexual risk behaviour of the first cohort undergoing screening for enrollment into Phase I/II HIV vaccine trials in South Africa. Int J STD AIDS. 2009;20(2):95-101.
37. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV prevalence, incidence, behaviour and communication survey, 2008: a turning tide among teenagers? Cape Town: Human Sciences Research Council Press; 2009.
38. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV prevalence, HIV incidence, behaviour and communication survey, 2005. Cape Town: Human Sciences Research Council Press; 2005.
39. Simbayi LC, Chauveau J, Shisana O. Behavioural responses of South African youth to the HIV/AIDS epidemic: a nationwide survey. AIDS Care. 2004;16(5):605-18. (Pubitemid 38918093)
40. Pettifor AE, Rees HV, Steffenson A, et al. (2004) HIV and sexual behavior among young South Africans: a national survey of 15-24 year olds. Johannesburg: reproductive health research unit, University of the Witwatersrand; 6 Apr.
41. The Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. Geneva: UNAIDS; 2006.
42. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191(9):1403-9. (Pubitemid 40563350)
43. Mehta SD, Gray RH, Auvert B, et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS. 2009; 23(12):1557-64.
44. Kigozi G, Gray RH, Wawer MJ, et al. The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med. 2008;5(6):e116.
45. Kalichman S, Eaton L, Pinkerton S. Circumcision for HIV prevention: failure to fully account for behavioral risk compensation. PLoS Med. 2007;4(3):e138.
46. Bailey R, Moses S, Parker C, et al. (2008) The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya Trial. XVII international AIDS conference. Mexico City, [abstract THAC0501].
47. Simonsen JN, Cameron DW, Gakinya MN, et al. Human immunodeficiency virus infection among men with sexually transmitted diseases: experience from a center in Africa. N Engl J Med. 1988;319(5):274-8.
48. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000;14(15):2361-70.
49. Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision- a systematic review with assessment of the quality of studies. Lancet Infect Dis. 2005;5(3):165-73. (Pubitemid 40568672)
50. Baeten JM, Richardson BA, Lavreys L, et al. Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men. J Infect Dis. 2005;191(4):546-53. (Pubitemid 40216670)
51. Gray RH, Kiwanuka N, Quinn TC, et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS. 2000;14(15):2371-81.
52. Meier AS, Bukusi EA, Cohen CR, Holmes KK. Independent association of hygiene, socioeconomic status, and circumcision with reduced risk of HIV infection among Kenyan men. J Acquir Immune Defic Syndr. 2006;43(1):117-8. (Pubitemid 44306498)
53. Gray R, Azire J, Serwadda D, et al. Male circumcision and the risk of sexually transmitted infections and HIV in Rakai, Uganda. AIDS. 2004;18(18):2428-30. (Pubitemid 40065911)
54. Auvert B, Buve A, Ferry B, et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS. 2001;15(Suppl 4):S15-30. (Pubitemid 32913001)
55. Auvert B, Buve A, Lagarde E, et al. Male circumcision and HIV infection in four cities in sub-Saharan Africa. AIDS. 2001; 15(Suppl 4):S31-40. (Pubitemid 32913002)
56. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342(13):921-9. (Pubitemid 30177052)
57. Rennie S, Muula AS, Westreich D. Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in lowincome countries. J Med Ethics. 2007;33(6):357-61.
58. Desai K, Boily MC, Garnett GP, Masse BR, Moses S, Bailey RC. The role of sexually transmitted infections in male circumcision effectiveness against HIV-insights from clinical trial simulation. Emerg Themes Epidemiol. 2006;3:19.
59. Cohen J. Prevention cocktails: combining tools to stop HIV's spread. Science. 2005;309(5737):1002-5. (Pubitemid 41134439)
60. Potts M, Halperin DT, Kirby D, et al. Public health: reassessing HIV prevention. Science. 2008;320(5877):749-50. (Pubitemid 351929614)
61. Coates TJ, Richter L, Caceres C, Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372(9639):669-84.
62. de Bruyn G, Smith MD, Gray GE, et al. Circumcision for prevention against HIV: marked seasonal variation in demand and potential public sector readiness in Soweto, South Africa. Implement Sci. 2007;2:2.
63. Scott BE, Weiss HA, Viljoen JI. The acceptability of male circumcision as an HIV intervention among a rural Zulu population, Kwazulu-Natal, South Africa. AIDS Care. 2005;17(3):304-13. (Pubitemid 40188912)
64. Rain-Taljaard RC, Lagarde E, Taljaard DJ, et al. Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection. AIDS Care. 2003;15(3): 315-27. (Pubitemid 36718391)
65. de Bruyn G, Martinson NA, Nkala BD, et al. Uptake of male circumcision in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2009;51(1):108-10.
66. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1- discordant couples in Rakai, Uganda. Lancet. 2001;357(9263): 1149-53. (Pubitemid 32378686)
67. The National Institute of Allergy and Infectious Diseases (NIAID), the National Institutes of Health (NIH), and the Department of Health and Human Services (DHHS). Workshop Summary: Scientific evidence of condom effectiveness for sexually transmitted disease (STD) prevention. Herndon, Virginia: NIAID, NIH & DHHS. 12-13 Jun 2000.
68. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS. 2002;16(4):597-603. (Pubitemid 34218855)
69. Owens DK, Edwards DM, Shachter RD. Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics. AIDS. 1998;12(9):1057-66.
70. Edwards DM, Shachter RD, Owens DK. A dynamic HIV-transmission model for evaluating the costs and benefits of vaccine programs. Interfaces. 1998;28(3):144-66.
71. Statistics South Africa. Mid-year population estimates, south africa: 2004. Pretoria: statistics South Africa. 27 Jul 2004.
72. The Actuarial Society of South Africa. ASSA2000 Model. Available at: http://www.actuarialsociety.org.za/Accessed 20 Oct 2007.
73. Statistics South Africa. 2001 South African census. Available at: www.statssa.gov.za. Accessed 20 Oct 2007.
74. Centre for AIDS development, research and evaluation (CADRE). HIV prevalence, incidence, behavior and communication survey 2005. Available at: www.cadre.org.za. Accessed 11 Jan 2006.